返回
Solving slot allocation problem with multiple ATFM measures by using enhanced meta-heuristic algorithm
DOI:10.1016/j.cie.2021.107602.png)
摘要
En 中文
In Air Traffic Flow Management (ATFM), one key issue is to determine the Calculated Take Off Time (CTOT) for each flight. Due to the limited slot time resources, one single flight's slot decision could be influenced by plenty of other flights. Few existing approaches in the previous literatures consider the interaction among various flights, so that the possible solution achieved will perform low stability and performance, especially under the condition of multiple measures. Aiming to solve the resource and flights coupling problems, in this paper, we present one heuristic method based on multi-dimension flight priority, with novel proposed methods of slot division and flight ranking. Meanwhile, in order to improve the optimality and flexibility of solutions, Estimation of Distribution Algorithm (EDA) is adopted. As one meta-heuristic algorithm, EDA is used to optimize the assignment sequence based on probability model, by which to provide an enhanced approach to solve slot allocation optimization problems. The numerical experiments have been conducted, the comparison results show that our approach has high calculation performance compared with conventional meta-heuristic algorithm-based approach, and better stability and applicability for re-allocation under the dynamic situation.
Keyword:
Air traffic flow management
Slot allocation
Priority-based rule
Meta-heuristic optimization
AI总结
对已上传原文的论文进行重点信息的提取,主要内容包括:简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
IF:
6.5
论文数:
1.0W
被引数:
3.8W
机构
引用论文
A Simultaneous Optimization Model for Airport Network Slot Allocation under Uncertain Capacity
SUSTAINABILITY
IF3.3
Increased Susceptibility to No. 2 Fuel Oil Coincident with Initiation of Particle Feeding in Developing Mud Snails, Ilyanassa obsoleta
Estuaries
IF0
A hybrid multi-objective EDA for robust resource constraint project scheduling with uncertainty具有不确定性的鲁棒资源约束项目调度的混合多目标EDA
Bendamustine Combined with Rituximab (BR) in First-Line Therapy of Advanced CLL: A Multicenter Phase II Trial of the German CLL Study Group (GCLLSG).
Blood
IF0

